NEWLINK GENETICS CORP NLNK Income Statement

Newlink genetics corp (NLNK)

Income statement / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10
Grant revenue
-	-	-	-	-	-	-	-	-	-	39,542	30,490	-	26,121	25,029	27,047	32,358	29,589	19,025	15,957	6,642	3,641	1,105	1,125	1,093	1,098	1,160	1,518	1,687	1,689	1,792	1,739	1,872	1,946	0	0	0
Licensing and collaboration revenue
-	-	-	-	-	-	-	-	-	-	1,637	2,331	-	4,596	4,552	7,967	36,143	200,505	199,661	195,496	165,950	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating revenues
936	705	579	2,680	12,474	17,754	0	0	-	0	-	-	-	-	-	-	-	-	-	211,453	172,592	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating revenues
-	-	-	-	-	-	-	-	-	-	41,179	32,821	-	37,274	29,374	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Research and development
22,205	23,186	23,732	30,583	45,694	57,433	68,343	74,455	69,866	71,895	77,878	87,088	93,300	88,605	86,650	75,370	71,414	68,552	56,940	47,285	35,691	28,966	24,195	22,757	22,713	21,994	20,648	20,351	17,838	17,328	15,850	14,905	14,255	14,224	0	0	0
General and administrative
23,865	24,910	24,219	26,493	29,218	30,480	30,799	31,784	31,726	32,221	32,063	32,296	33,226	33,725	33,360	31,487	30,689	31,290	28,837	24,443	19,328	14,044	11,370	10,771	9,521	8,625	7,764	7,651	7,108	7,131	6,836	5,821	5,679	5,092	0	0	0
Total operating expenses
46,070	48,096	47,951	57,076	74,912	87,913	99,142	106,239	101,592	104,116	109,941	119,384	126,526	122,330	120,010	106,857	102,103	99,842	85,777	71,728	55,019	43,010	35,565	33,528	32,234	30,619	28,412	28,002	24,946	24,459	22,686	20,726	19,934	19,316	0	0	0
Loss from operations
-45,134	-47,391	-47,372	-54,396	-62,438	-65,543	-71,410	-70,389	-72,881	-72,800	-68,762	-86,563	-90,758	-91,613	-90,429	-71,843	-33,602	130,252	132,909	139,725	117,573	-39,369	-34,460	-32,403	-31,141	-29,521	-27,252	-26,484	-23,259	-22,770	-20,894	-18,987	-18,062	-17,370	0	0	0
Other income and expense:
Miscellaneous (expense) income
-19	-156	-141	-121	-102	-9	21	-98	-126	-145	0	0	-	0	-	-	-14	-15	63	3	60	42	21	51	91	68	71	71	-62	-42	-53	-45	-26	26	0	0	0
Miscellaneous expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Miscellaneous income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	97	97	97	-38	-17	-17	-17	5	63	0	0	0
Forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-
Forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Interest income
2,226	2,334	2,431	2,268	2,029	1,773	1,260	916	616	410	327	276	237	190	147	107	78	90	85	80	86	70	52	33	12	9	10	12	14	12	11	11	11	9	0	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	26	26	29	30	33	38	36	38	38	37	47	39	42	46	0	0	0
Interest expense
50	51	28	40	52	54	55	26	119	120	122	121	22	106	105	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income, net
2,157	2,127	2,262	2,107	1,875	1,710	1,226	792	371	265	124	183	247	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before taxes
-42,977	-45,264	-45,110	-52,289	-60,563	-63,833	-70,184	-69,597	-72,510	-75,542	-89,265	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss before taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-71,856	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax (expense) benefit
12	32	-6,968	-6,968	-6,968	-7,130	-249	-249	-559	-764	-1,953	-4,032	-5,356	1,717	3,185	3,435	6,738	29,029	21,456	23,285	21,616	-7,283	130	130	130	0	0	0	-	-	-	-	-	-	-	-	-
Less net loss attributable to noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-1	-36	0	0	0
Net loss
-42,989	-45,287	-38,142	-45,321	-53,595	-56,712	-69,935	-69,348	-71,951	-71,771	-66,685	-82,348	-85,155	-93,223	-93,589	-75,291	-40,381	0	0	0	-	-	-	-	-	-	-	-26,413	-23,321	-22,812	-20,947	-19,032	-18,087	-17,308	0	0	0
Basic and diluted loss per share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.82	-	-0.55	-0.49	0.40	-	-	-	-0.33	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (loss) earnings per share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.35	-	-	-	-0.33	-	-	-	-	-	-	-	-	-	-1.09	-1.20	-	-
Basic and diluted average shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,856	-	28,734	28,661	28,218	-	-	-	27,605	-	-	-	-	-	-	-	-	-	3,658	3,646	3,636	3,371
Diluted average shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31,919	-	-	-	27,605	-	-	-	-	-	-	-	-	-	-	-	3,636	3,371
Net loss before taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-22,812	-20,947	-19,032	-18,088	-17,344	0	0	0
Basic and diluted loss per share (in dollars per share)
-0.22	-0.39	-0.27	-0.27	-0.28	-0.20	-0.47	-0.49	-0.32	-0.69	-0.57	-0.72	-	-0.54	-1.12	-	-	-	-	-	-	-0.20	-0.33	-	-	-0.32	-0.28	-0.33	-	-0.28	-0.31	-0.23	-	-	-	-1.07	-1.49
Basic and diluted average shares outstanding (in shares)
37,317	37,308	37,276	37,275	37,230	37,214	37,165	37,155	36,838	29,939	29,225	29,213	-	28,983	28,891	-	-	-	-	-	-	27,914	27,876	-	-	25,702	25,620	23,860	-	20,887	20,684	20,613	-	-	-	-	-
Grant revenue
Revenues
-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License and collaboration revenue
Revenues
-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-